Therapy success in cases of depression and ongoing pension applications;Botulinum toxin treatment einfluss von depression und laufendem rentenverfahren auf den therapieerfolg

Nervenarzt

Volumn 80, Issue 6, 2009, Pages 712-716

  Bachhuber, A ^a   Reichel, G ^a   Doberenz, M ^a   Stenner, A ^a   Hermann, W ^a  

^a Paracelsus Klinik

Author keywords

Botulinum toxin; Depression; Extensor digitorum brevis test; Pension; Therapy failure

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL EVALUATION; DEPRESSION; DISEASE COURSE; DISEASE DURATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PENSION; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; DISABILITY; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXINS; DEPRESSION; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PENSIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67651246900     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2690-8     Document Type: Article

References (29)

1. Bachhuber A, Wagner A, Reichel G et al (2009) Vergleich des Extensor Digitorum Brevis-Test mit dem Mouse Diaphragma Bioassay beim Nachweis von Botulinumtoxin Antikörper. Nervenarzt (im Druck)
2. Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. In: Clin Psychol Rev 77-100
3. Benecke 2007 Disabil Rehabil 29 1769
4. Berweck 2007 Dev Med Child Neurol 49 62
5. Borodic 1996 Neurology 46 26
6. Bortz J, Lienert GA (2008) Kurzgefasste Statistik für die klinische Forschung: Leitfaden für die verteilungsfreie Analyse kleiner Stichproben. Springer, Berlin
7. Brin 1988 Adv Neurol 50 599
8. Dengler 1992 J Neurol 239 375
9. Dressler 2002 Eur Neurol 48 26
10. Dressler 2004 Eur Neurol 52 132
11. Dressler 2002 Mov Disord 17 170
12. Dressler 2005 Mov Disord 20 1617
13. Gobel 2003 Schmerz 17 149
14. Greene 1994 Mov Disord 9 213
15. Hamjian 1994 Muscle Nerve 17 1385
16. Hautzinger M (1989) Internationale Depressionsdiagnostik. Z Klin Psychol 174-175
17. Moraru 2002 Depress Anxiety 16 100
18. Naumann M, Jost W (2004) Botulinum toxin treatment of secretory disorders. Mov Disord 19 [Suppl 8]:137-141
19. Oliver 1984 J Consult Clin Psychol 52 892
20. Poonyathalang 2005 Jpn J Ophthalmol 49 327
21. Roberts 1991 J Am Acad Child Adolesc Psychiatry 30 58
22. Siatkowski 1993 Ophthalmology 100 1861
23. Skogseid 2007 Eur J Neurol 14 1129
24. Slawek 2007 Funct Neurol 22 95
25. Sloop 2001 Mov Disord 16 100
26. Wenzel 1998 J Psychosom Res 44 687
27. White 2006 Dermatol Surg 32 212
28. Wissel 1997 Mov Disord 12 722
29. Zuber 1993 Neurology 43 1715